CHIMERIC THERAPEUTICS LIMITED - Announcements

33.3%

0.4¢

Market Cap $12.99M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CHM	Change in substantial holding - PH		29/07/25	121.63KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	1.24MB	Share
CHM	Proposed issue of securities - CHM		28/07/25	14.83KB	Share
CHM	Notification regarding unquoted securities - CHM		25/07/25	18.25KB	Share
CHM	Application for quotation of securities - CHM		25/07/25	15.93KB	Share
CHM	Notification regarding unquoted securities - CHM		25/07/25	18.33KB	Share
CHM	Application for quotation of securities - CHM		25/07/25	15.92KB	Share
CHM	Update - Proposed issue of securities - CHM		24/07/25	26.06KB	Share
CHM	Proposed issue of securities - CHM		23/07/25	23.43KB	Share
CHM	Prospectus		23/07/25	556.44KB	Share
CHM	Results of Meeting		23/07/25	165.96KB	Share
CHM	Presentation to Extraordinary General Meeting		23/07/25	2.34MB	Share
CHM	Initial Director's Interest Notice		02/07/25	241.53KB	Share
CHM	Change of Director's Interest Notice LR		01/07/25	103.41KB	Share
CHM	Professor Miles Prince appointed as Non-Executive Director		01/07/25	181.68KB	Share
CHM	Notification of cessation of securities - CHM		26/06/25	13.44KB	Share
CHM	Notice of Extraordinary General Meeting/Proxy Form		24/06/25	1.04MB	Share
CHM	Translational data shows persistence of CHM CDH17		17/06/25	277.09KB	Share
CHM	Chimeric receives $2.5 M advance on FY25 R&D tax incentive	PRICE SENSITIVE	10/06/25	188.91KB	Share
CHM	CHM CDH17 receives FDA Fast Track	PRICE SENSITIVE	04/06/25	196.96KB	Share
CHM	Application for quotation of securities - CHM		29/05/25	15.5KB	Share
CHM	Change in substantial holding - PH		28/05/25	122.14KB	Share
CHM	Application for quotation of securities - CHM		26/05/25	15.64KB	Share
CHM	Letter to Shareholders		26/05/25	206.15KB	Share
CHM	Prospectus		26/05/25	428.54KB	Share
CHM	Presentation to investor webinar		22/05/25	1.84MB	Share
CHM	CHM CDH17 ADVANCES TO DOSE LEVEL 2	PRICE SENSITIVE	21/05/25	296.35KB	Share
CHM	Investor webinar		20/05/25	169.64KB	Share
CHM	Proposed issue of securities - CHM		20/05/25	26.11KB	Share
CHM	Proposed issue of securities - CHM		20/05/25	15.45KB	Share
CHM	$6.6 million Placement to advance clinical trial pipeline	PRICE SENSITIVE	20/05/25	240.5KB	Share
CHM	Trading Halt	PRICE SENSITIVE	16/05/25	263.8KB	Share
CHM	ADVENT-AML Phase 1B clinical trial update	PRICE SENSITIVE	15/05/25	233.01KB	Share
CHM	Trading Halt	PRICE SENSITIVE	15/05/25	182.97KB	Share
CHM	Pause in Trading	PRICE SENSITIVE	15/05/25	112.72KB	Share
CHM	Application for quotation of securities - CHM		09/05/25	15.84KB	Share
CHM	Change in substantial holding		01/05/25	118.95KB	Share
CHM	Change of Director's Interest Notice PH		01/05/25	112.04KB	Share
CHM	Change of Director's Interest Notice		01/05/25	111.78KB	Share
CHM	Application for quotation of securities - CHM		30/04/25	16KB	Share
CHM	Application for quotation of securities - CHM		30/04/25	15.88KB	Share
CHM	EMORY JOINS CHM CDH17 PHASE 1/2 CLINICAL TRIAL		24/04/25	271.1KB	Share
CHM	Completion of Entitlement Offer	PRICE SENSITIVE	24/04/25	252.53KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	23/04/25	1.66MB	Share
CHM	Letter to CHMAAC option holders		04/04/25	180.83KB	Share
CHM	Update - Proposed issue of securities - CHM		03/04/25	20.98KB	Share
CHM	Entitlement Offer closing date extended to 22 April 2025		03/04/25	294.9KB	Share
CHM	Option Exp 19 Dec 2025 Range of Units and Top 20 Holders		02/04/25	299.63KB	Share
CHM	Application for quotation of securities - CHM		02/04/25	17.27KB	Share
CHM	US patent allowed for CHM CDH17 technology		25/03/25	213.79KB	Share
CHM	Entitlement Offer Documents		25/03/25	962.9KB	Share
CHM	Proposed issue of securities - CHM		18/03/25	14.73KB	Share
CHM	Update - Proposed issue of securities - CHM		18/03/25	21.44KB	Share
CHM	Prospectus	PRICE SENSITIVE	18/03/25	641.94KB	Share
CHM	Entitlement Offer to raise approximately $3.2 million	PRICE SENSITIVE	18/03/25	317.85KB	Share
CHM	Application for quotation of securities - CHM		17/03/25	15.9KB	Share
CHM	Presentation at NWR Virtual Healthcare Conference		13/03/25	213.27KB	Share
CHM	Reinstatement to Quotation	PRICE SENSITIVE	04/03/25	87.35KB	Share
CHM	Proposed issue of securities - CHM		04/03/25	21.5KB	Share
CHM	Chimeric announces intention to undertake Entitlement Offer	PRICE SENSITIVE	04/03/25	244.69KB	Share
CHM	Suspension from Quotation	PRICE SENSITIVE	03/03/25	629.46KB	Share
CHM	Half Year Report and Appendix 4D 31 December 2024	PRICE SENSITIVE	28/02/25	1.39MB	Share
CHM	$4.0m Non-Dilutionary Funding	PRICE SENSITIVE	27/02/25	239.76KB	Share
CHM	Trading Halt	PRICE SENSITIVE	27/02/25	570.57KB	Share
CHM	Pause in Trading	PRICE SENSITIVE	27/02/25	114.77KB	Share
CHM	Application for quotation of securities - CHM		12/02/25	15.61KB	Share
CHM	Prospectus		12/02/25	630.94KB	Share
CHM	Proposed issue of securities - CHM		11/02/25	13.78KB	Share
CHM	UChicago Medicine joins CHM CDH17 trial		10/02/25	240.02KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	1.33MB	Share
CHM	Notification regarding unquoted securities - CHM		23/12/24	15.79KB	Share
CHM	Notification of cessation of securities - CHM		23/12/24	12.87KB	Share
CHM	Notification regarding unquoted securities - CHM		23/12/24	18.65KB	Share
CHM	Phase 1B CHM CORE-NK trial advances to newly diagnosed AML	PRICE SENSITIVE	16/12/24	217.48KB	Share
CHM	Change of Director's Interest Notice PH		13/12/24	199.7KB	Share
CHM	Notification regarding unquoted securities - CHM		13/12/24	17.67KB	Share
CHM	Change in substantial holding - PH		11/12/24	228.05KB	Share
CHM	Update - Notification regarding unquoted securities - CHM		10/12/24	15.76KB	Share
CHM	Notice under section 708A		10/12/24	206.2KB	Share
CHM	Application for quotation of securities - CHM		10/12/24	15.81KB	Share
CHM	Notification regarding unquoted securities - CHM		10/12/24	15.73KB	Share
CHM	Notice under section 708A		09/12/24	206.97KB	Share
CHM	Application for quotation of securities - CHM		09/12/24	15.77KB	Share
CHM	Results of Meeting		04/12/24	228.79KB	Share
CHM	Presentation to Extraordinary General Meeting		04/12/24	4.69MB	Share
CHM	Chimeric receives $4.17m R&D tax incentive	PRICE SENSITIVE	28/11/24	174.74KB	Share
CHM	Constitution		14/11/24	615.29KB	Share
CHM	Results of Meeting		12/11/24	271.39KB	Share
CHM	AGM Presentation and CEO Appointment	PRICE SENSITIVE	12/11/24	13.52MB	Share
CHM	Notice under section 708A		05/11/24	206.37KB	Share
CHM	Application for quotation of securities - CHM		05/11/24	15.82KB	Share
CHM	Notice of Extraordinary General Meeting December 2024		05/11/24	374.55KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/24	906.01KB	Share
CHM	Investor webinar		24/10/24	174.63KB	Share
CHM	Dose finding complete in ADVENT-AML Phase 1b clinical trial		24/10/24	201.2KB	Share
CHM	Application for quotation of securities - CHM		24/10/24	15.6KB	Share
CHM	Prospectus	PRICE SENSITIVE	23/10/24	591.46KB	Share
CHM	Reinstatement to Official Quotation	PRICE SENSITIVE	21/10/24	413.35KB	Share
CHM	ESG Report		21/10/24	1.01MB	Share
CHM	Corporate Governance Statement and Appendix 4G		21/10/24	447.66KB	Share

CHM Change in substantial holding - PH
29/07/25		121.63KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	1.24MB	Share
CHM Proposed issue of securities - CHM
28/07/25		14.83KB	Share
CHM Notification regarding unquoted securities - CHM
25/07/25		18.25KB	Share
CHM Application for quotation of securities - CHM
25/07/25		15.93KB	Share
CHM Notification regarding unquoted securities - CHM
25/07/25		18.33KB	Share
CHM Application for quotation of securities - CHM
25/07/25		15.92KB	Share
CHM Update - Proposed issue of securities - CHM
24/07/25		26.06KB	Share
CHM Proposed issue of securities - CHM
23/07/25		23.43KB	Share
CHM Prospectus
23/07/25		556.44KB	Share
CHM Results of Meeting
23/07/25		165.96KB	Share
CHM Presentation to Extraordinary General Meeting
23/07/25		2.34MB	Share
CHM Initial Director's Interest Notice
02/07/25		241.53KB	Share
CHM Change of Director's Interest Notice LR
01/07/25		103.41KB	Share
CHM Professor Miles Prince appointed as Non-Executive Director
01/07/25		181.68KB	Share
CHM Notification of cessation of securities - CHM
26/06/25		13.44KB	Share
CHM Notice of Extraordinary General Meeting/Proxy Form
24/06/25		1.04MB	Share
CHM Translational data shows persistence of CHM CDH17
17/06/25		277.09KB	Share
CHM Chimeric receives $2.5 M advance on FY25 R&D tax incentive
10/06/25	PRICE SENSITIVE	188.91KB	Share
CHM CHM CDH17 receives FDA Fast Track
04/06/25	PRICE SENSITIVE	196.96KB	Share
CHM Application for quotation of securities - CHM
29/05/25		15.5KB	Share
CHM Change in substantial holding - PH
28/05/25		122.14KB	Share
CHM Application for quotation of securities - CHM
26/05/25		15.64KB	Share
CHM Letter to Shareholders
26/05/25		206.15KB	Share
CHM Prospectus
26/05/25		428.54KB	Share
CHM Presentation to investor webinar
22/05/25		1.84MB	Share
CHM CHM CDH17 ADVANCES TO DOSE LEVEL 2
21/05/25	PRICE SENSITIVE	296.35KB	Share
CHM Investor webinar
20/05/25		169.64KB	Share
CHM Proposed issue of securities - CHM
20/05/25		26.11KB	Share
CHM Proposed issue of securities - CHM
20/05/25		15.45KB	Share
CHM $6.6 million Placement to advance clinical trial pipeline
20/05/25	PRICE SENSITIVE	240.5KB	Share
CHM Trading Halt
16/05/25	PRICE SENSITIVE	263.8KB	Share
CHM ADVENT-AML Phase 1B clinical trial update
15/05/25	PRICE SENSITIVE	233.01KB	Share
CHM Trading Halt
15/05/25	PRICE SENSITIVE	182.97KB	Share
CHM Pause in Trading
15/05/25	PRICE SENSITIVE	112.72KB	Share
CHM Application for quotation of securities - CHM
09/05/25		15.84KB	Share
CHM Change in substantial holding
01/05/25		118.95KB	Share
CHM Change of Director's Interest Notice PH
01/05/25		112.04KB	Share
CHM Change of Director's Interest Notice
01/05/25		111.78KB	Share
CHM Application for quotation of securities - CHM
30/04/25		16KB	Share
CHM Application for quotation of securities - CHM
30/04/25		15.88KB	Share
CHM EMORY JOINS CHM CDH17 PHASE 1/2 CLINICAL TRIAL
24/04/25		271.1KB	Share
CHM Completion of Entitlement Offer
24/04/25	PRICE SENSITIVE	252.53KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
23/04/25	PRICE SENSITIVE	1.66MB	Share
CHM Letter to CHMAAC option holders
04/04/25		180.83KB	Share
CHM Update - Proposed issue of securities - CHM
03/04/25		20.98KB	Share
CHM Entitlement Offer closing date extended to 22 April 2025
03/04/25		294.9KB	Share
CHM Option Exp 19 Dec 2025 Range of Units and Top 20 Holders
02/04/25		299.63KB	Share
CHM Application for quotation of securities - CHM
02/04/25		17.27KB	Share
CHM US patent allowed for CHM CDH17 technology
25/03/25		213.79KB	Share
CHM Entitlement Offer Documents
25/03/25		962.9KB	Share
CHM Proposed issue of securities - CHM
18/03/25		14.73KB	Share
CHM Update - Proposed issue of securities - CHM
18/03/25		21.44KB	Share
CHM Prospectus
18/03/25	PRICE SENSITIVE	641.94KB	Share
CHM Entitlement Offer to raise approximately $3.2 million
18/03/25	PRICE SENSITIVE	317.85KB	Share
CHM Application for quotation of securities - CHM
17/03/25		15.9KB	Share
CHM Presentation at NWR Virtual Healthcare Conference
13/03/25		213.27KB	Share
CHM Reinstatement to Quotation
04/03/25	PRICE SENSITIVE	87.35KB	Share
CHM Proposed issue of securities - CHM
04/03/25		21.5KB	Share
CHM Chimeric announces intention to undertake Entitlement Offer
04/03/25	PRICE SENSITIVE	244.69KB	Share
CHM Suspension from Quotation
03/03/25	PRICE SENSITIVE	629.46KB	Share
CHM Half Year Report and Appendix 4D 31 December 2024
28/02/25	PRICE SENSITIVE	1.39MB	Share
CHM $4.0m Non-Dilutionary Funding
27/02/25	PRICE SENSITIVE	239.76KB	Share
CHM Trading Halt
27/02/25	PRICE SENSITIVE	570.57KB	Share
CHM Pause in Trading
27/02/25	PRICE SENSITIVE	114.77KB	Share
CHM Application for quotation of securities - CHM
12/02/25		15.61KB	Share
CHM Prospectus
12/02/25		630.94KB	Share
CHM Proposed issue of securities - CHM
11/02/25		13.78KB	Share
CHM UChicago Medicine joins CHM CDH17 trial
10/02/25		240.02KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	1.33MB	Share
CHM Notification regarding unquoted securities - CHM
23/12/24		15.79KB	Share
CHM Notification of cessation of securities - CHM
23/12/24		12.87KB	Share
CHM Notification regarding unquoted securities - CHM
23/12/24		18.65KB	Share
CHM Phase 1B CHM CORE-NK trial advances to newly diagnosed AML
16/12/24	PRICE SENSITIVE	217.48KB	Share
CHM Change of Director's Interest Notice PH
13/12/24		199.7KB	Share
CHM Notification regarding unquoted securities - CHM
13/12/24		17.67KB	Share
CHM Change in substantial holding - PH
11/12/24		228.05KB	Share
CHM Update - Notification regarding unquoted securities - CHM
10/12/24		15.76KB	Share
CHM Notice under section 708A
10/12/24		206.2KB	Share
CHM Application for quotation of securities - CHM
10/12/24		15.81KB	Share
CHM Notification regarding unquoted securities - CHM
10/12/24		15.73KB	Share
CHM Notice under section 708A
09/12/24		206.97KB	Share
CHM Application for quotation of securities - CHM
09/12/24		15.77KB	Share
CHM Results of Meeting
04/12/24		228.79KB	Share
CHM Presentation to Extraordinary General Meeting
04/12/24		4.69MB	Share
CHM Chimeric receives $4.17m R&D tax incentive
28/11/24	PRICE SENSITIVE	174.74KB	Share
CHM Constitution
14/11/24		615.29KB	Share
CHM Results of Meeting
12/11/24		271.39KB	Share
CHM AGM Presentation and CEO Appointment
12/11/24	PRICE SENSITIVE	13.52MB	Share
CHM Notice under section 708A
05/11/24		206.37KB	Share
CHM Application for quotation of securities - CHM
05/11/24		15.82KB	Share
CHM Notice of Extraordinary General Meeting December 2024
05/11/24		374.55KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
30/10/24	PRICE SENSITIVE	906.01KB	Share
CHM Investor webinar
24/10/24		174.63KB	Share
CHM Dose finding complete in ADVENT-AML Phase 1b clinical trial
24/10/24		201.2KB	Share
CHM Application for quotation of securities - CHM
24/10/24		15.6KB	Share
CHM Prospectus
23/10/24	PRICE SENSITIVE	591.46KB	Share
CHM Reinstatement to Official Quotation
21/10/24	PRICE SENSITIVE	413.35KB	Share
CHM ESG Report
21/10/24		1.01MB	Share
CHM Corporate Governance Statement and Appendix 4G
21/10/24		447.66KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.001(33.3%)		Mkt cap ! $12.99M

Open	High	Low	Value	Volume
0.3¢	0.4¢	0.3¢	$949	312.2K

Buyers (Bids)

No.	Vol.	Price($)
70	67782438	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	91927011	27

View Market Depth

No.	Vol.	Price($)
70	67782438	0.003
26	26746044	0.002
13	54414000	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	91927011	27
0.005	33248062	21
0.006	17929018	21
0.007	6512518	7
0.008	7317101	5

Last trade - 16.10pm 30/07/2025 (20 minute delay)


Last 0.3¢		Change 0.001 ( 0.00 %)
Open	High	Low	Volume
0.3¢	0.3¢	0.3¢	2120000
Last updated 15.54pm 30/07/2025 ?

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available